Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTRON LIMITED Director's Dealing 2025

Apr 9, 2025

64528_rns_2025-04-09_2f9a67e1-0982-420d-b53d-b44f8ceb5824.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [229 x 36] intentionally omitted <==

Level 2, 66 Hunter Street Sydney NSW 2000 Tel: (61-2) 9300 3344 Fax: (61-2) 9221 6333 E-mail: [email protected] Website: www.biotron.com.au

10 April 2025

The Manager Companies ASX Limited 20 Bridge Street SYDNEY NSW 2000

(7 pages by email)

Dear Madam,

DIRECTORS’ INTERESTS

In accordance with Listing Rule 3.19A, I attach an Appendix 3Y, Change of Director's Interest Notice, for Michael J. Hoy, Michelle Miller and Robert Thomas.

This announcement has been approved by the Managing Director, Michelle Miller.

Yours sincerely

==> picture [91 x 60] intentionally omitted <==

Peter J. Nightingale Company Secretary

pjn12590

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.


urposes of section 205G of the Corporations Act.

Name of Director Michael J. HOY
Date of last notice 28 November 2024.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Umbiram Pty Limited A/C> in which Michael Hoy has a beneficial interest.
Date of change 8 April 2025.
No. of securities held prior to change 11,217,352 fully paid ordinary shares held by
Umbiram Pty Limited A/C>.
Class Ordinary shares
Number acquired 11,217,353
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation.
$0.003
No. of securities held after change 22,434,705 fully paid ordinary shares held by
Umbiram Pty Limited A/C>.
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back.
Ordinary shares acquired under a rights issue
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or
contracts detailed above traded during
a+closed period where prior written
clearance was required?
No.
If so, was prior written clearance
provided to allow the trade to proceed
during this period?
N/A.
If prior written clearance was provided,
on what date was thisprovided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2 Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Michelle Miller
Date of last notice 28 November 2024.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to
the relevant interest.
Michelle Miller + Peter Clarke A/C> in which Michelle Miller has a beneficial interest.
Date of change 8 April 2025
No. of securities held prior to change 1,987,500 fully paid ordinary shares held by Michelle Miller.
1,800,000 fully paid ordinary shares held by Michelle Miller +
Peter Clarke
Class Ordinary Shares
Number acquired 1,987,500 acquired by Michelle Miller.
1,800,000 acquired by Michelle Miller + Peter Clarke Clarke Super Fund A/C>
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation.
$0.003
No. of securities held after change 3,975,000 fully paid ordinary shares held by Michelle Miller.
3,600,000 fully paid ordinary shares held by Michelle Miller +
Peter Clarke .
Nature of change
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment
plan,participation in buy-back.
Ordinary shares acquired under a rights issue.
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the
securities or contracts detailed
above traded during a+closed
period where prior written
clearance was required?
No.
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A.
If prior written clearance was
provided, on what date was this
provided?
N/A.
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Robert B. Thomas
Date of last notice 28 November 2024.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to
therelevant interest.
Murtoa Flour Mills Pty Ltd in
which Robert Thomas has a beneficial interest.
Date of change 8 April 2025.
No. of securities held prior to change 4,200,000 fully paid ordinary shares held by Murtoa Flour
Mills Pty Ltd
Class Ordinary Shares
Number acquired 4,200,000
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation.
$0.003
No. of securities held after change 8,400,000 fully paid ordinary shares held by Murtoa Flour
Mills Pty Ltd
Nature of change
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment
plan,participation in buy-back.
Ordinary shares acquired under a rights issue.
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities
or contracts detailed above traded
during a+closed period where
prior written clearance was
required?
No.
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A.
If prior written clearance was
provided, on what date was this
provided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011